Amilcare Parisi1, Jacopo Desiderio1, Roberto Cirocchi2, Stefano Trastulli3. 1. Department of Emergency and Digestive Surgery, St. Mary's Hospital, 05100, Terni, Italy. 2. Department of Surgical and Biomedical Sciences, University of Perugia, St. Mary's Hospital, 05100, Terni, Italy. 3. Department of Emergency and Digestive Surgery, St. Mary's Hospital, 05100, Terni, Italy. stefano.trastulli@hotmail.it.
Abstract
OBJECTIVE: Our aim was to conduct an up-to-date systematic review of randomised controlled trials (RCTs) to determine the benefits and harms of enhanced recovery after surgery (ERAS) programme in bariatric surgery. METHODS: MEDLINE, Embase, PubMed, CINAHL and the Cochrane Library were searched for RCTs on ERAS versus standard care (SC) until April 2020. The primary endpoint was the length of hospital stay (LOS). RESULTS: Five RCTs included a total of 610 procedures. ERAS adoption is capable of significantly reducing LOS (MD of - 0.51; 95% CI - 0.92 to - 0.10; P = 0.01) and postoperative nausea and vomiting (PONV) (OR 0.42; 95% CI 0.19 to 0.95; P = 0.04). No significant differences in terms of adverse events and readmissions. CONCLUSIONS: The implementation of ERAS in bariatric surgery produces a significant reduction in LOS and PONV.
OBJECTIVE: Our aim was to conduct an up-to-date systematic review of randomised controlled trials (RCTs) to determine the benefits and harms of enhanced recovery after surgery (ERAS) programme in bariatric surgery. METHODS: MEDLINE, Embase, PubMed, CINAHL and the Cochrane Library were searched for RCTs on ERAS versus standard care (SC) until April 2020. The primary endpoint was the length of hospital stay (LOS). RESULTS: Five RCTs included a total of 610 procedures. ERAS adoption is capable of significantly reducing LOS (MD of - 0.51; 95% CI - 0.92 to - 0.10; P = 0.01) and postoperative nausea and vomiting (PONV) (OR 0.42; 95% CI 0.19 to 0.95; P = 0.04). No significant differences in terms of adverse events and readmissions. CONCLUSIONS: The implementation of ERAS in bariatric surgery produces a significant reduction in LOS and PONV.
Authors: Guido H H Mannaerts; Stefanie R van Mil; Pieter S Stepaniak; Martin Dunkelgrün; Marcel de Quelerij; Serge J Verbrugge; Hans F Zengerink; L Ulas Biter Journal: Obes Surg Date: 2016-02 Impact factor: 4.129
Authors: A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo Journal: World J Surg Date: 2016-09 Impact factor: 3.352
Authors: Hugo Meunier; Yannick Le Roux; Anne-Lise Fiant; Yoann Marion; Adrien Lee Bion; Thomas Gautier; Nicolas Contival; Jean Lubrano; Fabienne Fobe; Marion Zamparini; Marie-Astrid Piquet; Véronique Savey; Arnaud Alves; Benjamin Menahem Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: Stacy A Brethauer; Arielle Grieco; Teresa Fraker; Kimberly Evans-Labok; April Smith; Matthew D McEvoy; Alan A Saber; John M Morton; Anthony Petrick Journal: Surg Obes Relat Dis Date: 2019-09-23 Impact factor: 4.734
Authors: Piotr Małczak; Magdalena Pisarska; Major Piotr; Michał Wysocki; Andrzej Budzyński; Michał Pędziwiatr Journal: Obes Surg Date: 2017-01 Impact factor: 4.129
Authors: Erik Stenberg; Luiz Fernando Dos Reis Falcão; Mary O'Kane; Ronald Liem; Dimitri J Pournaras; Paulina Salminen; Richard D Urman; Anupama Wadhwa; Ulf O Gustafsson; Anders Thorell Journal: World J Surg Date: 2022-01-04 Impact factor: 3.352
Authors: Nicolas H Dreifuss; Carolina Vanetta; Francisco Schlottmann; Antonio Cubisino; Alberto Mangano; Carolina Baz; Francesco M Bianco; Antonio Gangemi; Chandra Hassan; Mario A Masrur Journal: Obes Surg Date: 2022-10-04 Impact factor: 3.479